This paper is proposed to identify both promising technologies and potential products in the domain of biosensor using patent-based Technology-Driven Technology Roadmaps (TRM).

The technology-driven TRM with timelines in this study is developed in three layers: technology, function and product. Patent applications are collected and identified to interpret technologies and functions for biosensors in healthcare, and product manuals or releases can be used as product introductions.

Most biosensors in healthcare patents are concentrated in biochemical (T2) and electroencephalography (T5). Glycated hemoglobin (F1), measuring of glucose (F3), and biological process and molecular systems (F6) have a relatively larger patent count. Biochemical (T2) can combine with biological process and molecular systems (F6), and then brain's real-time electrical activity monitoring can be handled. Biochemical (T2) can also devote to glycated hemoglobin (F1), and glucose monitoring (F3), and thus create QCM sensor, CGM and GlucoWatch etc. applications.

Biochemical (T2) has a wide application among different functions for wearable biosensors in healthcare. This paper identifies and explores new developments biochemical (T2), and electroencephalography (T5) in wearable biosensors are expected to play a significant role over the coming decade in improving the current healthcare infrastructure, and enhancing the democratization of information and allocation of medical resources.

Three-layer technology-driven TRM contributed to the current understanding of whole picture and progress of technologies and functions in the domain of wearable biosensors.